Cutting Edge: TGF-β and Phosphatidylinositol 3-Kinase Signals Modulate Distinct Metabolism of Regulatory T Cell Subsets
Year: 2018
Type: article
Abstract: Murine Foxp3+ regulatory T cells (Tregs) differentiated in vitro (induced Tregs [iTregs]) in the presence of anti-inflammatory cytokine TGF-β rely predominantly upon lipid oxidation to fuel mitochondrial oxidative phosphorylation. Foxp3 expression underlies this metabolic preference, as it suppresses glycolysis and drives oxidative phosphorylation. In this study, we show that in contrast to iTregs, thymic-derived Tregs (tTregs), engage in glycolysis and glutaminolysis at levels comparable to effector T cells despite maintained Foxp3 expression. Interestingly, exposure of tTregs to the anti-inflammatory cytokine TGF-β represses PI3K-mediated mTOR signaling, inhibits glucose transporter and Hk2 expression, and reprograms their metabolism to favor oxidative phosphorylation. Conversely, replicating the effects of inflammation via elevation of PI3K signaling has minimal effects on tTregs but dramatically enhances the glycolysis of normally oxidative iTregs, resulting in reduction of Foxp3 expression. Collectively, these findings suggest both extrinsic and intrinsic factors govern the unique metabolic signature of Treg subsets.
Source: The Journal of Immunology
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Awards: T-Cell Targeting for GVHD, Costimulation and Cytokines in Tolerance, New Approaches to Cardiothoracic Tolerance Induction, Training in Transplantation Biology, Targeting T cell glutamine metabolism in severe asthma, T Cell Costimulatory Pathways: Functions and Interactions, Transplant Tolerance in Non-Human Primates, Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease, Enhancing Treg Therapeutic Efficacy in GVHD, Off-the-Shelf Immune Effector Cells for Hematological Malignancies
OpenAlex ID: W2889755393
